NCT06458387

Brief Summary

Protein malnutrition in critically ill patients is a global concern due to its association with prolonged hospital stays, and higher morbidity rates. Patients who undergo abdominal surgery are particularly vulnerable due to alterations in gastrointestinal function and prolonged fasting. Despite the significance of proper nutrition, the optimal target of protein supplementation remains controversial. The investigators aimed to evaluate the effects of high protein provision, targeting a protein intake of at least 1.5 g/kg/day for the first 3 days after abdominal surgery, on 6-month mortality.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable

Timeline
13mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Jul 2024Jun 2027

First Submitted

Initial submission to the registry

June 5, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
18 days until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Expected
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

1.5 years

First QC Date

June 5, 2024

Last Update Submit

June 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • 6-month mortality rate

    Proportion of patients who died within 6 months after surgery among participants

    Participants were followed up to 180 days immediately after the surgery

Secondary Outcomes (3)

  • 30-day mortality rate

    Participants were followed up to 30 days immediately after the surgery

  • 90-day mortality rate

    Participants were followed up to 90 days immediately after the surgery

  • Incidence of postoperative complications

    Participants were followed during hospitalization (up to 14 days)

Study Arms (2)

Active protein supplementation

EXPERIMENTAL

The participants in active nutritional supplementation arm received nutritional support targeting specific protein (over 1.5 g/kg/day), with consultation from the nutritional support team and the initiation of nutritional supplementation on the same day as intensive care unit admission.

Dietary Supplement: Active protein supplementation

Conventional protein supplementation

EXPERIMENTAL

The participants in conventional protein supplementation arm underwent conventional nutrition management without specific protein targets, but less than 1.5 g/kg/day.

Dietary Supplement: Conventional protein supplementation

Interventions

The participants in active nutritional supplementation arm received consultation from the nutritional support team (NST) upon ICU admission, and nutritional supplementation was initiated on the same day. NST is a multidisciplinary support team comprised of physicians, nurses, dietitians, and pharmacists, which assesses the nutritional status of patients, and provides recommendations for nutritional therapy. Targets in the participants in active protein supplementation arm were protein supplementation at over 1.5 g/kg/day during first 3 days after ICU admission. Actual body weight was used as the body weight for patients with a percent of ideal body weight (PIBW) of less than 120%, while adjusted body weight was used for patients with a PIBW greater than or equal to 120%.

Active protein supplementation

The participants in conventional protein supplementation arm received conservative nutritional management without specific protein targets.

Conventional protein supplementation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients admitted after abdominal surgery to our institution's surgical ICU
  • They were enrolled regardless of the surgical method, either open, laparoscopy, or robotic.

You may not qualify if:

  • aged under 18 years
  • underwent surgery under local or regional anesthesia
  • pregnant
  • readmitted to the ICU due to any cause
  • diagnosed with renal failure and receiving renal replacement therapy
  • patients diagnosed with multiorgan failure, represented by a high Sequential Organ Failure Assessment (SOFA) score (≥9) upon ICU admission
  • failed to provide informed consent, or with 'do-not-resuscitate' status.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary's Hospital

Seoul, Seocho-gu, Banpo-dong Banpodaero 222, 137-701, South Korea

Location

MeSH Terms

Conditions

Kwashiorkor

Condition Hierarchy (Ancestors)

Severe Acute MalnutritionMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Hye sung Kim

    The Catholic University of Korea

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 5, 2024

First Posted

June 13, 2024

Study Start

July 1, 2024

Primary Completion

January 1, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

June 13, 2024

Record last verified: 2024-06

Locations